NVET
Nexvet Biopharma plc Ordinary Shares
NVET
NVET
Delisted
NVET was delisted on the 28th of July, 2017.
18 hedge funds and large institutions have $18.9M invested in Nexvet Biopharma plc Ordinary Shares in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$919K | |
| 2 | +$479K | |
| 3 | +$45.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.28K |
Top Sellers
| 1 | -$1.57M | |
| 2 | -$60K | |
| 3 | -$44K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$6.39K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.9K |